# Trade Mark Journal No.2025/039 26 September 2025

## WO0000001874708 (5)

Office of origin: United States of America

Date of International Registration:25 July 2025
Date of designation in the UK: 25 July 2025

International priority date claimed: 28 January 2025 (United States of America) (99020576)

Class 5
  Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical use.

Vedanta Biosciences, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA